Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 7, 2013, Pages 1143-1149

  Hewitt, Nathan A ^a   O'Connor, Alicia A ^a   O'Shaughnessy, Denise V ^b   Elder, Grahame J ^c,d  

^a UNIVERSITY OF NOTRE DAME   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLECALCIFEROL; OSTEVIT D; PARATHYROID HORMONE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CLINICAL EVALUATION; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GASTROINTESTINAL DISEASE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PARAMETERS; PULSE WAVE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BIOMECHANICAL PHENOMENA; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEALTH STATUS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MUSCLE STRENGTH; NEW SOUTH WALES; PULSE WAVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84879829145     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02840312     Document Type: Article

References (40)

1. Institute of Medicine: Dietary Reference Intakes for Calcium and Vitamin D, Washington, DC, The National Academies Press, 2011.
2. Jean G, Terrat J-C, Vanel T, Hurot J-M, Lorriaux C, Mayor B, Chazot C: Daily oral 25-hydroxycholecalciferol supplementation for vitaminDdeficiency in haemodialysis patients: Effects on mineral metabolism and bone markers. Nephrol Dial Transplant 23: 3670-3676, 2008.
3. Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D, Ballanti P, Bonucci E: 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int 68: 1840-1848, 2005.
4. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR: Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 11: 315-321, 2007.
5. Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, Ritz E, Wanner C, Boeschoten EW, Brandenburg V; NECOSAD Study Group: Vitamin D status and clinical outcomes in incident dialysis patients: Results from the NECOSAD study. Nephrol Dial Transplant 26: 1024-1032, 2011.
6. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007.
7. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349: 446-456, 2003.
8. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J AmSoc Nephrol 16: 1115-1125, 2005.
9. Tentori F, Albert JM, Young EW, Blayney MJ, Robinson BM, Pisoni RL, Akiba T, Greenwood RN, Kimata N, Levin NW, Piera LM, Saran R, Wolfe RA, Port FK: The survival advantage for haemodialysis patients taking vitamin D is questioned: Findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 24: 963-972, 2009.
10. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y: Lower risk for cardiovascular mortality in oral 1a-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19: 179-184, 2004.
11. Tokuda N, Kano M, Meiri H, Nomoto K, Naito S: Calcitriol therapy modulates the cellular immune responses in hemodialysis patients. Am J Nephrol 20: 129-137, 2000.
12. Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238, 2002.
13. Elstner E, Linker-Israeli M, Said J, Umiel T, de Vos S, Shintaku IP, Heber D, Binderup L, Uskokovic M, Koeffler HP: 20-epi-vitamin D3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 55: 2822-2830, 1995.
14. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M: Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
15. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, Jaccard N, Knoll E, Stern N: 25-hydroxyvitamin D3-1ahydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111: 1666-1671, 2005.
16. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18: 613-620, 2007.
17. Elder GJ: Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology (Carlton) 12: 90-94, 2007.
18. Boudville N, Inderjeeth C, Elder GJ, Glendenning P: Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure. Clin Endocrinol (Oxf) 73: 299-304, 2010.
19. Anand S, Kaysen GA, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, Kurella Tamura M: Vitamin D deficiency, selfreported physical activity and health-related quality of life: The Comprehensive Dialysis Study. Nephrol Dial Transplant 26: 3683-3688, 2011.
20. Kidney Disease Improving Global Outcomes: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 76: S1-S130, 2009.
21. Working Group of the Australian and New Zealand Bone and Mineral Society; Endocrine Society of Australia; Osteoporosis Australia: Vitamin D and adult bone health in Australia and New Zealand: A position statement. Med J Aust 182: 281-285, 2005.
22. Armas LAG, Andukuri R, Barger-Lux J, Heaney RP, Lund R: 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis. Clin J Am Soc Nephrol 7: 1428-1434, 2012.
23. Lambert PW, Stern PH, Avioli RC, Brackett NC, Turner RT, Greene A, Fu IY, BellNH: Evidence for extrarenal production of 1 alpha, 25-dihydroxyvitaminDin man. J Clin Invest 69: 722-725, 1982.
24. Jean G, Souberbielle J-C, Chazot C: Monthly cholecalciferol administration in haemodialysis patients: A simple and efficient strategy for vitaminD supplementation. Nephrol Dial Transplant 24: 3799-3805, 2009.
25. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A: Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 5: 905-911, 2010.
26. González EA, Sachdeva A, Oliver DA, Martin KJ: Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24: 503-510, 2004.
27. Chu P, Chao T-Y, Lin Y-F, Janckila AJ, Yam LT: Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis 41: 1052-1059, 2003.
28. Kogawa M, Anderson PH, Findlay DM, Morris HA, Atkins GJ: The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol 121: 277-280, 2010.
29. Reference Values for Arterial Stiffness' Collaboration: Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'Establishing normal and reference values'. Eur Heart J 31: 2338-2350, 2010.
30. Henley C, Colloton M, Cattley RC, Shatzen E, Towler DA, Lacey D, Martin D: 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 20: 1370-1377, 2005.
31. Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GFM: Meta-analysis: Vitamin D compounds in chronic kidney disease. Ann Intern Med 147: 840-853, 2007.
32. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul M-C: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J AmSoc Nephrol 19: 1827-1835, 2008.
33. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L: A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19: 1239-1246, 2008.
34. Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, Thomas J, Lowndes C, Hopper JL, Wark JD: Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 53: 1881-1888, 2005.
35. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, Conzelmann M: Effects of vitamin D and calcium supplementation on falls: A randomized controlled trial. J Bone Miner Res 18: 343-351, 2003.
36. Zhu K, Austin N, Devine A, Bruce D, Prince RL: A randomized controlled trial of the effects of vitamin D onmuscle strength and mobility in older women with vitamin D insufficiency. J Am Geriatr Soc 58: 2063-2068, 2010.
37. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC: Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 303: 1815-1822, 2010.
38. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK: Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 64: 339-349, 2003.
39. Blair D, Byham-Gray L, Lewis E, McCaffrey S: Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr 18: 375-382, 2008.
40. Clive DR, Sudhaker D, Giacherio D, Gupta M, Schreiber MJ, Sackrison JL, MacFarlane GD: Analytical and clinical validation of a radioimmunoassay for the measurement of 1,25 dihydroxy vitamin D. Clin Biochem 35: 517-521, 2002